Skip to Main Content
LuminUltra
EnglishFrançais简体中文
LuminUltra Headquarters

LuminUltra’s response to COVID-19

Our Commitment

LuminUltra is committed to keeping you up-to-date on our response during this ever-changing time. Our focus is on supporting our people, including our employees, our partners, our customers, and their families. We will achieve this by embodying one of our core values: to remain flexible at all times. If you have any questions, please contact us.

Below are our most recent updates, regarding social distancing and business continuity.

COVID-19 testing

We are providing 500,000 urgently needed COVID-19 tests per week to the Canadian federal government for use across Canada.

Social distancing

We have followed guidelines to minimize interaction between people, including:

  • implemented a work-from-home policy for all staff that are able to do so
  • pause on all travel and in-person meetings, instead leveraging the variety of technology options at our disposal to maintain close communication

Business continuity

We recognize during the quickly-changing time that customers may wish to increase their stock of our products. We are able to accommodate these requests. To inquire about additional stock, please contact sales@luminultra.com.

We remain focused on maintaining delivery and support of our products, including:

  • taking steps to ensure the continuity of our test kit and equipment supply chain, from raw materials to production to shipment capabilities
  • optimizing production and inventory levels
  • increasing capacity for mail-in testing services such as qPCR and Next-Generation Sequencing

In addition, we continue to work on launching our new products that will further facilitate testing through data interpretation, training, and automation.

For information on the 2019 novel coronavirus and water supply, please visit the USEPA, WHO, and CDC websites.


LuminUltra Team

Founded in 1995, LuminUltra is a molecular biology diagnostic testing company headquartered in Canada with operations in 6 countries. It is widely recognized globally as a leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring applications and is a key supplier of COVID-19 diagnostic testing reagents to the Government of Canada.

Dozens of Fortune 500 customers across more than 80 countries trust LuminUltra’s technology, production reliability and history of customer service excellence to deliver their essential services in a safe state.

Related Posts

LuminUltra Headquarters

LuminUltra Will Supply 500,000 COVID-19 tests per week to Canadian Government

April 15th, 2020 Fredericton, New Brunswick – Canadian biotechnology leader LuminUltra today announced that it will provide 500,000 urgently needed COVID-19 tests per week to the Canadian federal government for use across Canada. In his press conference earlier today, Prime Minister Justin Trudeau announced that New Brunswick-based LuminUltra is ramping up its production capacity to… Read More

Pearson airport COVID-19

Made-in-Canada: LuminUltra’s rapid, portable qPCR solutions a game-changer for COVID-19 testing at Canada’s largest airport

The Greater Toronto Airport Authority announced that starting March 1 it will use LuminUltra’s game-changing rapid, portable COVID-19 qPCR testing solution on-site at Pearson International Airport, as part of a federally funded research study. The biotechnology front-runner’s GeneCount® COVID-19 RT-qPCR Assay Kit is authorized by Health Canada for sale and distribution.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now